A. Coppell

Bi-phasic change in BDNF gene expression following antidepressant drug treatment

T. Zetterström, A. Coppell, Q. Pei, 2003, Neuropharmacology.

Characterisation using microphysiometry of CRF receptor pharmacology.

D. Smart, A. McKnight, C. Rossant, 1999, European journal of pharmacology.

In vitro enzymatic processing of radiolabelled big ET-1 in human kidney.

A. Davenport, F. Russell, A. Coppell, 1998, Biochemical pharmacology.

An Open-Label, Positron Emission Tomography Study to Assess Adenosine A2A Brain Receptor Occupancy of Vipadenant (BIIB014) at Steady-State Levels in Healthy Male Volunteers

D. Brooks, S. Papapetropoulos, P. He, 2010, Clinical neuropharmacology.

Next‐generation Bruton's tyrosine kinase inhibitor BIIB091 selectively and potently inhibits B cell and Fc receptor signaling and downstream functions in B cells and myeloid cells

M. Mingueneau, Baohong Zhang, S. Belachew, 2021, Clinical & translational immunology.

Manipulations of brain 5-HT levels affect gene expression for BDNF in rat brain

T. Zetterström, D. Grahame-Smith, A. Coppell, 1999, Neuropharmacology.